Literature DB >> 15157990

Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain.

Shupeng Li1, Kun Yang Kim, Jong Hun Kim, Jin Hoi Kim, Moon Seok Park, Jong Yoon Bahk, Myeong Ok Kim.   

Abstract

Previous pharmacokinetics and electrophysiological results indicated an important role of nicotine in the modulation of dopamine transporter (DAT). To elucidate the expression changes of DAT on chronic nicotine and smoke administration, the effects of nicotine and passive cigarette smoke on DAT mRNA expression in the ventral tegmental area (VTA) and the substantia nigra (SN) area were examined using in situ hybridization and RNase protection assay. The results showed that chronic nicotine and smoke exposure highly unregulated DAT mRNA in the VTA and SN areas, including the dorsal part of substantia nigra pars compacta. Smoke for 30 min showed the highest increasing effect, whereas nicotine and smoke for 10 min only had slightly increasing effects. However, smoke for 1 h showed an increasing effect to a lesser extent than 30 min. These results revealed a new aspect of nicotine's modulation on the DAT, and may have important roles in neuropsychological disorders related to the midbrain abnormalities such as drugs addiction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157990     DOI: 10.1016/j.neulet.2004.03.053

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Secondhand smoke exposure and mental health in adults: a meta-analysis of cross-sectional studies.

Authors:  Yan-Ni Zeng; Ya-Min Li
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-12-10       Impact factor: 4.328

Review 3.  Cellular events in nicotine addiction.

Authors:  Rachel E Penton; Robin A J Lester
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

4.  Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.

Authors:  Jose J Mateos; Francisco Lomeña; Eduard Parellada; Font Mireia; Emili Fernandez-Egea; Javier Pavia; Alberto Prats; Francisca Pons; Miquel Bernardo
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

Review 5.  Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction.

Authors:  Natalie A Hadad; Lori A Knackstedt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-06       Impact factor: 4.530

6.  What are candidate biobehavioral mechanisms underlying the association between secondhand smoke exposure and mental health?

Authors:  Frank C Bandiera
Journal:  Med Hypotheses       Date:  2011-09-07       Impact factor: 1.538

Review 7.  Functional brain imaging of tobacco use and dependence.

Authors:  Arthur L Brody
Journal:  J Psychiatr Res       Date:  2005-06-24       Impact factor: 4.791

Review 8.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 9.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Induction of tyrosine hydroxylase mRNA by nicotine in rat midbrain is inhibited by mifepristone.

Authors:  Pheona M Radcliffe; Carol R Sterling; A William Tank
Journal:  J Neurochem       Date:  2009-03-23       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.